tiprankstipranks
AIM ImmunoTech announces follow-up clinical study of Ampligen with FluMist
PremiumThe FlyAIM ImmunoTech announces follow-up clinical study of Ampligen with FluMist
25d ago
AIM ImmunoTech announces Safety Committee approval to proceed with Phase 2
Premium
The Fly
AIM ImmunoTech announces Safety Committee approval to proceed with Phase 2
27d ago
AIM ImmunoTech files to sell units, no amount given
Premium
The Fly
AIM ImmunoTech files to sell units, no amount given
1M ago
AIM ImmunoTech receives noncompliance notification from NYSE
PremiumThe FlyAIM ImmunoTech receives noncompliance notification from NYSE
3M ago
AIM ImmunoTech expands patent portfolio with new Netherlands patent
Premium
The Fly
AIM ImmunoTech expands patent portfolio with new Netherlands patent
3M ago
Kellner Group says former AIM ImmunoTech executive supports nominees
Premium
The Fly
Kellner Group says former AIM ImmunoTech executive supports nominees
3M ago
AIM ImmunoTech: ‘Activist Group slate is wrong vhoice’ for shareholders
PremiumThe FlyAIM ImmunoTech: ‘Activist Group slate is wrong vhoice’ for shareholders
3M ago
Kellner Group urges AIM ImmunoTech stockholders to vote for its nominees
Premium
The Fly
Kellner Group urges AIM ImmunoTech stockholders to vote for its nominees
3M ago
AIM ImmunoTech Aligns Compensation with Shareholder Strategy
Premium
Company Announcements
AIM ImmunoTech Aligns Compensation with Shareholder Strategy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100